XML 19 R7.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Cash Flows from Operating Activities:    
Net income $ 154,465 $ 113,231
Adjustments to reconcile net income to net cash provided (used) by operating activities:    
Depreciation and amortization 40,893 38,210
Impairment charge   2,228
Provision for uncollectible accounts 825 252
Benefit of deferred income taxes 2,691 1,516
Share-based compensation expense 11,742 9,927
Other 206 1,540
Tax benefit from share-based compensation arrangements (Note 2)   (4,791)
Changes in assets and liabilities:    
Accounts receivable (32,400) (23,647)
Inventories (18,850) 214
Other assets and liabilities (21,426) (3,994)
Accounts payable 1,422 99
Deferred revenue 1,898 3,088
Net cash provided by operating activities 141,466 137,873
Cash Flows from Investing Activities:    
Purchases of property and equipment (38,566) (37,868)
Purchase of marketable securities (175,522) (123,809)
Proceeds from the sale and maturities of marketable securities 155,903 108,115
Acquisitions of a business, net of cash acquired (14,529)  
Net cash used by investing activities (72,714) (53,562)
Cash Flows from Financing Activities:    
Borrowings (repayments) on revolving credit facilities, net 93,000 (15,000)
Debt issue costs   (57)
Repurchases of common stock (170,798) (76,536)
Proceeds from exercises of stock options and employee stock purchase plans 23,170 17,554
Payment of acquisition-related contingent consideration   (2,717)
Shares withheld for statutory tax withholding on restricted stock (Note 2) (7,459) (3,732)
Tax benefit from share-based compensation arrangements (Note 2)   4,791
Net cash used by financing activities (62,087) (75,697)
Net effect of changes in exchange rates on cash 4,409 3,531
Net increase in cash and cash equivalents 11,074 12,145
Cash and cash equivalents at beginning of period 154,901 128,994
Cash and cash equivalents at end of period $ 165,975 $ 141,139